At present, he is the executive director of the National Veterinary Medicine Association and the National Poultry Association. He is the vice president of Hebei Animal Husbandry Association, Hebei Animal Health Products Association and Hebei Feed Industry Association. It has been awarded "Top 3 Comprehensive Strength of National Veterinary Drug Preparations", "Advanced Unit of Intellectual Property (Patent) Work in Hebei Province", "Trustworthy Unit of Quality of China Animal Health Products Association", "Advanced Unit of Tax Payment", "Advanced Unit of Earthquake Relief" and "Sponsor Unit of Feed Safety in Hebei Province". It is one of the first sponsors of the "National Strategic Alliance for Innovation of Chinese Veterinary Drugs"; It is one of the founding units of the strategic alliance of innovative technology of Chinese veterinary drugs in Hebei Province. It is the vanguard of the innovation and development of veterinary drugs in Hebei Province over the years. The company consists of Shijiazhuang Shizhong Veterinary Medicine Quality Control Technology Center, Hebei Enterprise Technology Center, Import and Export Trade Department, Production Department, Domestic Business Department, Personnel Department and Finance Department. The annual sales capacity is 15 million yuan. The company's veterinary drug production involves more than 2 varieties in eleven series, including small-volume injections (including Chinese medicine extraction), large-volume intravenous injections, large-volume intravenous injections (including Chinese medicine extraction), tablets (including Chinese medicine extraction), powders, premixes, oral liquids (including Chinese medicine extraction), granules (including Chinese medicine extraction), disinfectants and pesticides. Products are sold all over Hebei, Henan, Hubei, Hunan and other 28 provinces (cities) and autonomous regions; The company has passed the international acceptance certification of many countries, and its products are sold to Sudan, Ethiopia, Russia, South Korea, South America and other countries, and have been well received by the international market. The company insists on developing enterprises through science and technology and takes the road of innovation and development. Has invested more than 22 million yuan, 1, established a modern R&D center and experimental base. At present, there are 35 researchers, including 28 with middle and senior titles. The research center consists of a biopharmaceutical center, a Chinese veterinary drug center and a standardization center. The center has more than 3 sets of large-scale scientific research instruments and equipment. Up to now, the company has undertaken 13 government research projects, including 2 national projects, 2 provincial projects, 9 municipal projects and 15 national patents.